State Street Corp Harmony Biosciences Holdings, Inc. Transaction History

State Street Corp

  • $2.8 Trillion
  • Q3 2025

A detailed history of State Street Corp transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, State Street Corp holds 1,653,604 shares of HRMY stock, worth $56.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,653,604
Previous 1,629,246 1.5%
Holding current value
$56.3 Million
Previous $51.5 Million 11.48%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$26.76 - $38.05 $651,820 - $926,821
24,358 Added 1.5%
1,653,604 $45.6 Million
Q2 2025

Aug 14, 2025
BUY
$27.94 - $35.91 $1.4 Million - $1.8 Million
50,212 Added 3.18%
1,629,246 $51.5 Million
Q1 2025

May 15, 2025
SELL
$32.18 - $40.46 $57,312 - $72,059
-1,781 Reduced 0.11%
1,579,034 $52.4 Million
Q4 2024

Feb 14, 2025
BUY
$31.86 - $41.49 $10.8 Million - $14.1 Million
340,217 Added 27.42%
1,580,815 $54.4 Million
Q3 2024

Nov 14, 2024
SELL
$30.0 - $39.95 $987,000 - $1.31 Million
-32,900 Reduced 2.58%
1,240,598 $49.6 Million
Q2 2024

Aug 14, 2024
SELL
$28.81 - $33.01 $635,145 - $727,738
-22,046 Reduced 1.7%
1,273,498 $38.4 Million
Q1 2024

May 15, 2024
SELL
$29.93 - $35.06 $1.94 Million - $2.28 Million
-64,903 Reduced 4.77%
1,295,544 $43.5 Million
Q4 2023

Feb 14, 2024
BUY
$19.2 - $33.78 $2.55 Million - $4.49 Million
132,986 Added 10.83%
1,360,447 $43.9 Million
Q3 2023

Nov 14, 2023
BUY
$31.89 - $39.03 $2.76 Million - $3.38 Million
86,527 Added 7.58%
1,227,461 $40.2 Million
Q2 2023

Aug 14, 2023
BUY
$30.5 - $37.4 $2.97 Million - $3.64 Million
97,337 Added 9.33%
1,140,934 $40.1 Million
Q1 2023

May 15, 2023
BUY
$30.8 - $53.92 $2.18 Million - $3.82 Million
70,814 Added 7.28%
1,043,597 $34.1 Million
Q4 2022

Feb 14, 2023
SELL
$45.4 - $60.91 $4.72 Million - $6.34 Million
-104,043 Reduced 9.66%
972,783 $53.6 Million
Q3 2022

Nov 15, 2022
BUY
$42.06 - $55.45 $5.57 Million - $7.35 Million
132,491 Added 14.03%
1,076,826 $47.7 Million
Q2 2022

Aug 15, 2022
BUY
$33.54 - $52.15 $3.9 Million - $6.06 Million
116,154 Added 14.03%
944,335 $46.1 Million
Q1 2022

May 16, 2022
BUY
$33.14 - $51.13 $1.74 Million - $2.68 Million
52,498 Added 6.77%
828,181 $40.3 Million
Q4 2021

Feb 14, 2022
BUY
$34.09 - $43.91 $12.9 Million - $16.6 Million
378,825 Added 95.46%
775,683 $33.1 Million
Q3 2021

Nov 15, 2021
BUY
$25.68 - $38.61 $2.42 Million - $3.63 Million
94,068 Added 31.07%
396,858 $15.2 Million
Q2 2021

Aug 16, 2021
BUY
$25.96 - $33.44 $5.59 Million - $7.2 Million
215,312 Added 246.13%
302,790 $8.55 Million
Q1 2021

May 17, 2021
BUY
$27.56 - $40.37 $129,532 - $189,739
4,700 Added 5.68%
87,478 $2.89 Million
Q4 2020

Feb 16, 2021
BUY
$31.74 - $51.34 $2.63 Million - $4.25 Million
82,778 New
82,778 $2.99 Million

Others Institutions Holding HRMY

# of Institutions
318
Shares Held
42.8M
Call Options Held
1.05M
Put Options Held
310K
View Full List

About Harmony Biosciences Holdings, Inc.

HRMY Quotes by TradingView
  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.01B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email